Results

Total Results: 1,185 records

Showing results for "author year description".

121. Disposition of Comments Report for Local Hepatic Therapies for Metastases to the Liver From Unresectable Colorectal Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_disposition-comments.pdf
     December 11, 2012 - The 5-year survival rate estimated by the National Cancer Institute Surveillance Epidemiology and End … The description of the review and the summary provided clearly shows that all relevant studies have … This study was excluded since it was thought that studies with treatment interventions prior to year … Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation … The article by Solibati et al was excluded due to a treatment period before year 2000.

122. Observed Association Between Antidepressant Use and Pneumonia Risk Was Confounded by Comorbidity Measures (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-seniors-pneumonia_research.pdf
     May 01, 2008 - ..................................................................................... 13 Author … The odds ratio (OR) for any antidepressant use, adjusting for age, sex, and calendar year was 1.61 ( … The OR for any antidepressant use, adjusted for age, sex, and calendar year was 1.45 (0.65 to 3.24). … Code Description AyuKA00 KLEBSIELLA PNEUMONIAE/CAUSE/DISEASE CLASSIFD/OTH CHAPTERS AyuK900 MYCOPLASMA … Code Description Hyu4700 [X]PNEUMONITIS DUE TO INHALATION OF OTHER SOLIDS AND LIQUIDS H470312 ASPIRATION

123. Disposition of Comments Report for Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
     September 15, 2014 - However we have now clarified the description and moved it so that it appears after the description … standard” and added more detail about the use of NIST and DEQAS standards as well as reporting the year … breast and colorectal cancer and for hip fracture conducted by Prentice and colleagues of the 7- year … Description of results in Table 33B report the increased risk at higher 25OHD levels. … MS, irrespective of year, country etc.

124. Disposition of Comments for CER 202 Effectiveness and Safety of Bronchial Thermoplasty in the Management of Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-202-thermoplasty-comments.pdf
     December 14, 2017 - Response Public Reviewer 11 David Peden on behalf of AAAAI Methods Further, related to the KQ2 Description … total (n=432) for the three clinical trials from which the conclusions were made under the heading “Description … and 5 year data. … Nonetheless, description of the patients phenotype would be helpful as well as characterization of previous … prior to treatment to 50.4 percent in year one and 46.4 percent in year two

125. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
     March 10, 2010 - Methods We find it unfortunate that the literature searches ended over a year ago. … Considerable literature has been published in the past year that is directly relevant to the subject … A systematic review that fails to include information that is as much as a year old is not a useful … Timelines: Letters from Chalmers to lead authors: April 16 to May 2, 2008 Forwarded to Merck by lead author … in the population description with ?muscle-related side effects.?

126. Prompt Reduction in Use of Medications for Comorbid Conditions After Bariatric Surgery | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/bariatric-surgery/research
     July 30, 2010 - Author Affiliations Jodi B. Segal, M.D., M.P.H. a Jeanne M. Clark, M.D., M.P.H. a Andrew D. … the change in use of medications to treat diabetes mellitus, hypertension, and hyperlipidemia in the year … We compared the mean number of medications at the time of surgery and in the subsequent year. … We created additional variables for description and to use in modeling outcomes, including demographics … Description of the Development and Validation of a Propensity Score for Obesity Introduction Obesity

127. Disposition of Comments for CER 162 Diagnosis of Celiac Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/celiac-disease_disposition-comments.pdf
     January 28, 2016 - introduction to the main body as well as the background of the executive summary should qualify the description

128. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence.pdf
     October 26, 2020 - Author Emily Gean Charlotte Armstrong Robin Paynter Conflict of Interest: None of the investigators … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … References Author Impact of a New Evidence Review Yes.

129. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_2.pdf
     October 26, 2020 - Author Emily Gean Charlotte Armstrong Robin Paynter Conflict of Interest: None of the investigators … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … References Author Impact of a New Evidence Review Yes.

130. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_1.pdf
     October 26, 2020 - Author Emily Gean Charlotte Armstrong Robin Paynter Conflict of Interest: None of the investigators … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … References Author Impact of a New Evidence Review Yes.

131. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_0.pdf
     October 26, 2020 - Author Emily Gean Charlotte Armstrong Robin Paynter Conflict of Interest: None of the investigators … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … References Author Impact of a New Evidence Review Yes.

132. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_12.pdf
     October 26, 2020 - Author Emily Gean Charlotte Armstrong Robin Paynter Conflict of Interest: None of the investigators … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … References Author Impact of a New Evidence Review Yes.

133. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_11.pdf
     October 26, 2020 - Author Emily Gean Charlotte Armstrong Robin Paynter Conflict of Interest: None of the investigators … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … References Author Impact of a New Evidence Review Yes.

134. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_10.pdf
     October 26, 2020 - Author Emily Gean Charlotte Armstrong Robin Paynter Conflict of Interest: None of the investigators … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … References Author Impact of a New Evidence Review Yes.

135. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_9.pdf
     October 26, 2020 - Author Emily Gean Charlotte Armstrong Robin Paynter Conflict of Interest: None of the investigators … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … References Author Impact of a New Evidence Review Yes.

136. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_8.pdf
     October 26, 2020 - Author Emily Gean Charlotte Armstrong Robin Paynter Conflict of Interest: None of the investigators … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … References Author Impact of a New Evidence Review Yes.

137. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_7.pdf
     October 26, 2020 - Author Emily Gean Charlotte Armstrong Robin Paynter Conflict of Interest: None of the investigators … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … References Author Impact of a New Evidence Review Yes.

138. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_5.pdf
     October 26, 2020 - Author Emily Gean Charlotte Armstrong Robin Paynter Conflict of Interest: None of the investigators … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … References Author Impact of a New Evidence Review Yes.

139. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_6.pdf
     October 26, 2020 - Author Emily Gean Charlotte Armstrong Robin Paynter Conflict of Interest: None of the investigators … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … References Author Impact of a New Evidence Review Yes.

140. Topic Brief: Updating Treatments for Fecal Incontinence (pdf file)
     effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-fecal-incontinence_4.pdf
     October 26, 2020 - Author Emily Gean Charlotte Armstrong Robin Paynter Conflict of Interest: None of the investigators … The findings and conclusions in this document are those of the author(s) who are responsible for its … See Appendix B for detailed description of the criteria. … References Author Impact of a New Evidence Review Yes.